<DOC>
	<DOCNO>NCT00368147</DOCNO>
	<brief_summary>The purpose study determine creation fistula graft play role development heart disease patient undergoing hemodialysis</brief_summary>
	<brief_title>Access Creation Hemodialysis : Association With Structural Changes Heart</brief_title>
	<detailed_description>Patients end stage renal disease 18-20 time great risk die cardiovascular disease general population . Both traditional non-traditional cardiovascular risk factor think important . Of non-tradtional cardiovascular risk factor , creation arteriovenous fistula graft purpose blood access hemodialysis may contribute elevation BNP leave ventricular hypertrophy - factor associate increase risk mortality Prior access creation one month one year post access creation - sample BNP collect Prior access creation one year post access creation - echocardiography perform</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<criteria>1 ) Hemodialysis 2 ) high risk heart failure ( DM , age &amp; gt ; 50 , and/or systolic dysfunction ) 3 ) first arteriovenous fistula/graft 4 ) inform consent 5 ) technically adequate echocardiogram 6 ) stable hgb ( &amp; gt ; 100 ) 7 ) stable mineral metabolism ( normal calcium , phosphate &amp; lt ; 2.1mmol/L , PTH &amp; gt ; 50pmol/L ) 1 ) Expected survival &amp; lt ; 1 year 2 ) Expected get live donor transplant one year 3 ) primary access failure 4 ) ARF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>Arteriovenous Fistula</keyword>
	<keyword>Arteriovenous Graft</keyword>
	<keyword>Left Ventricular Hypertrophy</keyword>
	<keyword>Brain Natriuretic Peptide</keyword>
</DOC>